|
GTSE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.75620000156351E-08 |
| Normal-vs-Stage2 |
1.246150E-02 |
| Normal-vs-Stage3 |
1.61845999999688E-05 |
| Normal-vs-Stage4 |
1.802220E-02 |
| Stage1-vs-Stage2 |
6.944600E-01 |
| Stage1-vs-Stage3 |
1.496390E-03 |
| Stage1-vs-Stage4 |
1.256420E-01 |
| Stage2-vs-Stage3 |
1.036340E-02 |
| Stage2-vs-Stage4 |
1.378810E-01 |
| Stage3-vs-Stage4 |
5.770600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62658775337832E-12 |
| Normal-vs-AfricanAmerican |
2.01500000018839E-07 |
| Normal-vs-Asian |
1.015640E-01 |
| Caucasian-vs-AfricanAmerican |
1.148790E-01 |
| Caucasian-vs-Asian |
3.180000E-01 |
| AfricanAmerican-vs-Asian |
2.362200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.88098491916389E-15 |
| Normal-vs-Female |
1.64639999966631E-07 |
| Male-vs-Female |
6.398500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.34339999999933E-05 |
| Normal-vs-Extreme_Weight |
4.75129999788493E-08 |
| Normal-vs-Obese |
3.41290000038796E-07 |
| Normal-vs-Extreme_Obese |
8.355600E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.287200E-01 |
| Normal_Weight-vs-Obese |
8.373400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.639550E-02 |
| Extreme_Weight-vs-Obese |
9.644300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.186500E-02 |
| Obese-vs-Extreme_Obese |
2.495700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.238000E-04 |
| Normal-vs-Age(41-60Yrs) |
6.30695495829059E-12 |
| Normal-vs-Age(61-80Yrs) |
9.5179999992645E-08 |
| Normal-vs-Age(81-100Yrs) |
6.483900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.870000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.743810E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.781950E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.653380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.185840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.345800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.64122057558325E-13 |
| Normal-VS-Type2 PRCC |
1.51650000002057E-06 |
| Normal-VS-KIRP CIMP |
1.716060E-03 |
| Normal-VS-Unclassified PRCC |
1.026260E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.569500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.282300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.598200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.953700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.110000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.563800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.84799999999719E-05 |
| Normal-vs-N1 |
2.81030000004456E-06 |
| Normal-vs-N2 |
1.852790E-01 |
| N0-vs-N1 |
8.392400E-04 |
| N0-vs-N2 |
3.275400E-01 |
| N1-vs-N2 |
5.453400E-01 |
|
|
